Astellas agrees to ceasefire as it views confidential OSI information
This article was originally published in Scrip
Executive Summary
Astellas has agreed to hold off from certain actions associated with its attempt to buy OSI Pharmaceuticals until 15 May while it views confidential information being made available by its US target to potential bidders.